Membranes
AlloDerm SELECT RTM™/GBR
Since its introduction to dentistry in 1999, AlloDerm SELECT™ Regenerative Tissue Matrix (RTM) has been a widely accepted acellular dermal matrix (ADM) for soft tissue applications. As demonstrated in preclinical studies, AlloDerm SELECT™ supports tissue regeneration by allowing rapid revascularization and cell repopulation*1,2—ultimately transitioning into host tissue for a strong repair. (Thickness ranges from 0.9–1.6mm.)
Use of AlloDerm SELECT™ RTM results in reduced postoperative bleeding and swelling as reported in a case series3,†
No recognizable difference between AlloDerm SELECT™ RTM and connective tissue in terms of recession reduction, clinical attachment gain, and reduction in probing depth at six months4,‡
Most published ADM in implant dentistry5
Sterile and ready-to-use6
* Correlation of these results, based on animal studies, to results in humans has not been established
Before use, physicians should review all risk information, which can be found in the AlloDerm SELECT™ RTM Instructions for Use.
† Based on questionnaire given to 228 patients at 1 week post-treatment covering 331 procedures who received an AlloDerm SELECT™ RTM (n=89 procedures) or autogenous soft tissue (n=242 procedures) graft for gingival augmentation.
‡ Results obtained from 30 gingival recessions in 9 patients treated with AlloDerm SELECTTM RTM (15 recessions) or autogenous soft tissue (15 recessions).
Applications include -
root coverage
gingival augmentation
soft tissue augmentation around implants
mechanism of action
The processing of a biological material ultimately impacts the clinical outcome. The undamaged, intact dermal matrix that enables positive recognition and supports regeneration as demonstrated in preclinical models.1,2,7,†
Regenerative Tissue Matrix
Complex acellular heterogenous scaffold and blood vessel architecture; pre-hydrated and ready-to-use
† Correlation of these results, based on animal studies, to results in humans has not been established.